Effects of a Computerized Physician Order Entry (CPOE)-Based Inpatient Insulin Protocol on Glycemic Outcomes

Diabetes Mellitus Clinical Trial

Official title:

Effects of a Computerized Physician Order Entry (CPOE)-Based Inpatient Insulin Protocol on Glycemic Outcomes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00718198
• Other study ID #: 06-063 JHSEndo01
• Status: Completed
• Start date: March 2006
• Est. completion date: June 2008

Study information

• Verified date: November 2023
• Source: Cook County Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Retrospective cross-sectional study measuring the impact of a computer=based insulin correction protocol and nursing inservicing on diabetes outcomes

Description:

This study is a retrospective cross-sectional study at one institution, where the investigators compared diabetic patients admitted to Medicine Services from March-April 2006 (before CPOE was implemented) to patients admitted from October-November 2007 (one year after CPOE implementation). Capillary blood glucose values, Hemoglobin AIC, diabetes medication profile and demographic data were obtained to compare between groups. The investigators hypothesized that a computer-based protocol that emphasizes basal-bolus and correctional insulin orders and excludes sliding scale, in conjunction with nursing personnel inservicing, improves outcomes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 413
• Est. completion date: June 2008
• Est. primary completion date: December 2007
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of Diabetes Mellitus

Exclusion Criteria:

• Admitted to Non-Medicine Hospital Services

Related Conditions & MeSH terms

• Diabetes Mellitus

Locations

Country	Name	City	State
United States	John H. Stroger Jr. Hospital	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Cook County Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mean Inpatient Glucose	Baseline glucose	From day of admission to hospital until day of discharge from hospital
Secondary	Percentage of normoglycemic (70 to 150 mg/dl) patient-days	Percentage of inpatient days at glucose target	From day of admission to hospital until day of discharge from hospital
Secondary	Percentage of hyperglycemic patient-days	Percentage of inpatient days above glucose target	From day of admission to hospital until day of discharge from hospital
Secondary	Percentage of Patient-days with glucose less than 70 mg/dl	Percentage of inpatient days below glucose target	From day of admission to hospital until day of discharge from hospital
Secondary	Percentage of Patients with inpatient or recent (less than 6 months) hemoglobin AIC	Percentage of patients with recent A1c	From day of admission to hospital until day of discharge from hospital
Secondary	Length of stay	Number of days inpatient	From day of admission to hospital until day of discharge from hospital
Secondary	Distribution of oral hypoglycemic use	Rate of oral diabetes medication use	From day of admission to hospital until day of discharge from hospital
Secondary	Distribution of type of insulin therapy used	Rate of insulin use	From day of admission to hospital until day of discharge from hospital
Secondary	Percent of patient-days with severe hypoglycemia	Percentage of patient days with glucose below 55 mg/dL	From day of admission to hospital until day of discharge from hospital